Net Cash Provided by (Used in) Financing Activities of AdaptHealth Corp. from 31 Dec 2017 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
AdaptHealth Corp. annual and quarterly Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 31 Dec 2017 to 31 Dec 2025.
  • AdaptHealth Corp. Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2025 was $56,039,000, a 236% decline year-over-year.
  • AdaptHealth Corp. annual Net Cash Provided by (Used in) Financing Activities for 2025 was $302,192,000, a 52% decline from 2024.
  • AdaptHealth Corp. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $198,949,000, a 115% decline from 2023.
  • AdaptHealth Corp. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $92,528,000, a 40% decline from 2022.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)

AdaptHealth Corp. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $302,192,000 -$103,243,000 -52% 01 Jan 2025 31 Dec 2025 10-K 24 Feb 2026 2025 FY
2024 $198,949,000 -$106,421,000 -115% 01 Jan 2024 31 Dec 2024 10-K 24 Feb 2026 2025 FY
2023 $92,528,000 -$26,477,000 -40% 01 Jan 2023 31 Dec 2023 10-K 24 Feb 2026 2025 FY
2022 $66,051,000 -$1,664,790,000 -104% 01 Jan 2022 31 Dec 2022 10-K 25 Feb 2025 2024 FY
2021 $1,598,739,000 +$955,586,000 +149% 01 Jan 2021 31 Dec 2021 10-K 27 Feb 2024 2023 FY
2020 $643,153,000 +$567,009,000 +745% 01 Jan 2020 31 Dec 2020 10-K 28 Feb 2023 2022 FY
2019 $76,144,000 +$27,375,520 +56% 01 Jan 2019 31 Dec 2019 10-K 01 Mar 2022 2021 FY
2018 $48,768,480 01 Jan 2018 31 Dec 2018 10-K 06 Mar 2020 2019 FY

AdaptHealth Corp. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $56,039,000 -$97,329,000 -236% 01 Jan 2025 31 Mar 2025 10-Q 06 May 2025 2025 Q1
Q1 2024 $41,290,000 +$36,842,000 +828% 01 Jan 2024 31 Mar 2024 10-Q 06 May 2025 2025 Q1
Q1 2023 $4,448,000 +$21,000,000 01 Jan 2023 31 Mar 2023 10-Q 07 May 2024 2024 Q1
Q1 2022 $16,552,000 -$1,244,111,000 -101% 01 Jan 2022 31 Mar 2022 10-Q 09 May 2023 2023 Q1
Q1 2021 $1,227,559,000 +$1,169,324,000 +2008% 01 Jan 2021 31 Mar 2021 10-Q 10 May 2022 2022 Q1
Q1 2020 $58,235,000 +$58,603,761 01 Jan 2020 31 Mar 2020 10-Q 10 May 2021 2021 Q1
Q1 2019 $368,761 -$251,699,804 -100% 01 Jan 2019 31 Mar 2019 10-Q 08 May 2020 2020 Q1
Q1 2018 $251,331,043 01 Jan 2018 31 Mar 2018 10-Q 14 May 2019 2019 Q1
Q4 2017 $119,821* 22 Nov 2017 31 Dec 2017 10-K 29 Mar 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.